{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T13:20:56Z","timestamp":1765891256352,"version":"3.48.0"},"reference-count":39,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Council of the Pharmacy Association of Catalonia, Barcelona, Spain and the University of Barcelona, Barcelona, Spain"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Policy and Practice"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/20523211.2025.2457406","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T06:42:02Z","timestamp":1738910522000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Abuse and misuse of tramadol in patients with non-oncologic pain in a region of Southern Europe"],"prefix":"10.1080","volume":"18","author":[{"given":"M.","family":"Perell\u00f3","sequence":"first","affiliation":[{"name":"Council of the Pharmacist\u2019s Association of Catalonia","place":["Barcelona, Spain"]},{"name":"University of Barcelona","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Rio-Aig\u00e9","sequence":"additional","affiliation":[{"name":"University of Barcelona","place":["Barcelona, Spain"]},{"name":"Institute of Research in Nutrition and Food Safety (INSA)","place":["Santa Coloma de Gramenet, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Cereza","sequence":"additional","affiliation":[{"name":"Government of Catalonia","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Rius","sequence":"additional","affiliation":[{"name":"Council of the Pharmacist\u2019s Association of Catalonia","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. J.","family":"P\u00e9rez-Cano","sequence":"additional","affiliation":[{"name":"University of Barcelona","place":["Barcelona, Spain"]},{"name":"Institute of Research in Nutrition and Food Safety (INSA)","place":["Santa Coloma de Gramenet, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rabanal","sequence":"additional","affiliation":[{"name":"University of Barcelona","place":["Barcelona, Spain"]},{"name":"Institute of Research in Nutrition and Food Safety (INSA)","place":["Santa Coloma de Gramenet, Spain"]},{"name":"Government of Catalonia","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"unstructured":"Agency for Health Quality and Assessment of Catalonia. (2018). Care guide for patients with chronic non-oncological pain using opioid analgesics. Agency for Health Quality and Assessment of Catalonia Ministry of Health Government of Catalonia.","key":"e_1_3_4_2_1"},{"doi-asserted-by":"publisher","key":"e_1_3_4_3_1","DOI":"10.1002\/pds.4626"},{"doi-asserted-by":"publisher","key":"e_1_3_4_4_1","DOI":"10.1080\/17460441.2017.1377697"},{"unstructured":"Catalan Health Service. (2023). Report on the use of opioid medicines in Catalonia [Unpublished manuscript]. Catalan Health Service Ministry of Health.","key":"e_1_3_4_5_1"},{"unstructured":"Drug Enforcement Administration. (2014). Schedules of Controlled Substances: Placement of Tramadol Into Schedule IV. Drug Enforcement Administration. https:\/\/www.govinfo.gov\/content\/pkg\/FR-2014-07-02\/pdf\/2014-15548.pdf","key":"e_1_3_4_6_1"},{"unstructured":"FDA. (2018). Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS). FDA. https:\/\/www.fda.gov\/drugs\/information-drug-class\/opioid-analgesic-risk-evaluation-and-mitigation-strategy-rems","key":"e_1_3_4_7_1"},{"unstructured":"FDA. (2023). Adverse Events Reporting System (FAERS). FDA. https:\/\/fis.fda.gov\/sense\/app\/95239e26-e0be-42d9-a960-9a5f7f1c25ee\/sheet\/33a0f68e-845c-48e2-bc81-8141c6aaf772\/state\/analysis","key":"e_1_3_4_8_1"},{"doi-asserted-by":"publisher","key":"e_1_3_4_9_1","DOI":"10.1016\/S0095-4543(21)00378-X"},{"doi-asserted-by":"publisher","key":"e_1_3_4_10_1","DOI":"10.1016\/B978-0-12-800634-4.00040-8"},{"key":"e_1_3_4_11_1","first-page":"46","article-title":"New trends of prescription drug use in Spain","author":"Fonseca F.","year":"2014","unstructured":"Fonseca, F., Green, J. L., Maremmani, I., Touzeau, D., Walcher, S., Deruvo, G., Somaini, L., Martinez, D., Rossi, P., & Torrens, M. (2014). New trends of prescription drug use in Spain. Heroin Addict Relat Clin Probl, 46\u201347.","journal-title":"Heroin Addict Relat Clin Probl"},{"unstructured":"General Directorate of Addictions. (2020). Drug dependence information system in Catalonia: 2019. General Directorate of Addictions Ministry of Health Government of Catalonia.","key":"e_1_3_4_12_1"},{"unstructured":"General Pharmaceutical Council of Spain. (2025). The pharmacist profession in Spain. Farmac\u00e9uticos.com. Retrieved from https:\/\/www.farmaceuticos.com\/internacional\/pharmacy-in-spain\/pharmacist-profession-in-spain\/","key":"e_1_3_4_13_1"},{"unstructured":"Government of Catalonia. (2020). Be careful with tramadol it could increase mortality. Government of Catalonia. https:\/\/ics.gencat.cat\/ca\/detall\/article\/125_3#googtrans(ca\/en)","key":"e_1_3_4_14_1"},{"doi-asserted-by":"publisher","key":"e_1_3_4_15_1","DOI":"10.1111\/dar.13203"},{"doi-asserted-by":"publisher","key":"e_1_3_4_16_1","DOI":"10.1016\/j.drugalcdep.2020.108367"},{"doi-asserted-by":"publisher","key":"e_1_3_4_17_1","DOI":"10.1515\/jdpa-2016-0008"},{"doi-asserted-by":"publisher","key":"e_1_3_4_18_1","DOI":"10.3390\/ijerph19148600"},{"doi-asserted-by":"publisher","key":"e_1_3_4_19_1","DOI":"10.1111\/bcp.14408"},{"doi-asserted-by":"publisher","key":"e_1_3_4_20_1","DOI":"10.1213\/ANE.0000000000001683"},{"doi-asserted-by":"publisher","key":"e_1_3_4_21_1","DOI":"10.1136\/ejhpharm-2018-001749"},{"doi-asserted-by":"publisher","key":"e_1_3_4_22_1","DOI":"10.1080\/00325481.2018.1502569"},{"doi-asserted-by":"publisher","key":"e_1_3_4_23_1","DOI":"10.1111\/j.1533-2500.2008.00232.x"},{"doi-asserted-by":"publisher","key":"e_1_3_4_24_1","DOI":"10.3390\/ijerph18157818"},{"doi-asserted-by":"publisher","key":"e_1_3_4_25_1","DOI":"10.3389\/fpubh.2023.1116337"},{"key":"e_1_3_4_26_1","volume-title":"Therapeutics letter.","author":"Perry T.","year":"2021","unstructured":"Tramadol: Where do we go from here? (2021). In T. Perry (Ed.), Therapeutics letter. Therapeutics Initiative."},{"unstructured":"Pharmacovigilance Center of Catalonia. (2023). Directorate-General for Healthcare Planning and Regulation Ministry of Health [Unpublished data]. Government of Catalonia.","key":"e_1_3_4_27_1"},{"doi-asserted-by":"publisher","key":"e_1_3_4_28_1","DOI":"10.2515\/therapie\/2014221"},{"doi-asserted-by":"publisher","key":"e_1_3_4_29_1","DOI":"10.1111\/bcp.15323"},{"doi-asserted-by":"publisher","key":"e_1_3_4_30_1","DOI":"10.2196\/43776"},{"key":"e_1_3_4_31_1","volume-title":"Enquesta de salut de Catalunya, 2021","author":"Schiaffino A.","year":"2022","unstructured":"Schiaffino, A., & Medina, A. (2022). Enquesta de salut de Catalunya, 2021. Direcci\u00f3 General de Planificaci\u00f3 en Salut. https:\/\/scientiasalut.gencat.cat\/handle\/11351\/7854?show=full&locale-attribute=en."},{"doi-asserted-by":"publisher","key":"e_1_3_4_32_1","DOI":"10.1016\/S0376-8716(02)00321-6"},{"key":"e_1_3_4_33_1","volume-title":"Use of opioid analgesic medications in Spain","author":"Spanish Agency for Medicines and Medical Devices (AEMPS)","year":"2022","unstructured":"Spanish Agency for Medicines and Medical Devices (AEMPS). (2022). Use of opioid analgesic medications in Spain. AEMPS, Ministry of Health, Government of Spain."},{"doi-asserted-by":"publisher","key":"e_1_3_4_34_1","DOI":"10.1016\/j.biopha.2018.12.085"},{"doi-asserted-by":"publisher","key":"e_1_3_4_35_1","DOI":"10.1002\/pds.1838"},{"unstructured":"United Nations Office on Drugs and Crime. (2019). The World Drug Report 2019: Perspectives on protecting public health. United Nations. https:\/\/www.unodc.org\/wdr2019","key":"e_1_3_4_36_1"},{"unstructured":"UNODC. (2022). World Drug Report 2022. https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2022.html","key":"e_1_3_4_37_1"},{"unstructured":"World Health Organization. (2018). Critical review report: Tramadol. Expert Committee on Drug Dependence Forty-first Meeting. Geneva 12\u201316 November 2018.","key":"e_1_3_4_38_1"},{"doi-asserted-by":"publisher","key":"e_1_3_4_39_1","DOI":"10.3389\/fphar.2022.912361"},{"doi-asserted-by":"publisher","key":"e_1_3_4_40_1","DOI":"10.4137\/SART.S6174"}],"container-title":["Journal of Pharmaceutical Policy and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20523211.2025.2457406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T13:19:07Z","timestamp":1765891147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/20523211.2025.2457406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/20523211.2025.2457406"],"URL":"https:\/\/doi.org\/10.1080\/20523211.2025.2457406","relation":{},"ISSN":["2052-3211"],"issn-type":[{"type":"electronic","value":"2052-3211"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=jppp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=jppp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-02-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2457406"}}